Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03360604Not ApplicableCompleted

Utilizing Glycaemic Index: An Investigation of the Glycaemia and Cognition in Type 2 Diabetes

Role: lead

NCT03346746Not ApplicableCompleted

Utilizing GI: Exploring an Optimum Glycaemic Profile for Cognitive Function Across the Day

Role: lead

NCT03344185Not ApplicableCompleted

The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day

Role: lead

All 3 trials loaded